$MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$476.91
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMadrigal Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is MDGL up today? It is at $476.91 (+0.00%), and our scanner flagged it 77 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MDGL spikes, and full due diligence on MDGL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MDGL 77 times in the last 30 days. Create a free account to track $MDGL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MDGL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MDGL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMadrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors, from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Sep 28, 2026 · 10 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sibold William John Officer | Sold (automatic/other) | -5K 0.02% of company | sold 2.6% | 198K | $2.8M at $533.09 | Sep 11, 26 |
Sibold William John Officer | Sold (automatic/other) | -6K 0.03% of company | sold 3.0% | 203K | $3.4M at $527.88 | Sep 9, 26 |
Kelley Shannon T Officer | Sold (automatic/other) | -664 | sold 5.5% | 11K | $342K at $514.97 | Aug 17, 26 |
Reed John C Director | Acquired (grant/award) | +647 | n/a | 647 | n/a | Aug 15, 26 |
Sibold William John Officer | Sold (automatic/other) | -3K 0.01% of company | sold 1.2% | 209K | $1.4M at $542.75 | Jul 20, 26 |
Sibold William John Officer | Other | 50K 0.2% of company | added 31% | 212K | n/a | Jul 17, 26 |
Baker Bros. Advisors Lp Director | Acquired (grant/award) | +2K | added <0.1% | 2.15M | n/a | Jun 17, 26 |
Brennan Daniel J. Director | Acquired (grant/award) | +404 | added 42% | 1K | n/a | Jun 17, 26 |
Daly James M Director | Acquired (grant/award) | +454 | added 17% | 3K | n/a | Jun 17, 26 |
Fouse Jacqualyn A Director | Acquired (grant/award) | +454 | added 41% | 2K | n/a | Jun 17, 26 |
Levy Richard S Director | Acquired (grant/award) | +454 | added 2.1% | 22K | n/a | Jun 17, 26 |
Taub Rebecca Director | Acquired (grant/award) | +454 | added 0.1% | 453K | n/a | Jun 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MDGL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MDGL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MDGL last traded at $476.91, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is next expected to report earnings on Tuesday, November 3, 2026, about 25 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MDGL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MDGL 77 times in the last 30 days.
MDGL (Madrigal Pharmaceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $11.02B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MDGL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MDGL discussion
Sign in to ask a question or join the discussion.